6.723

  • ISSN
  • 20556837, 20556845
  • Open Access
  • Publisher
  • Oxford University Press
  • Country/Region
  • United Kingdom
  • History
  • Categories
  • Cardiology and Cardiovascular Medicine (Q1), Pharmacology (medical) (Q1)

European Heart Journal - Cardiovascular Pharmacotherapy - ISSN

The ISSN of European Heart Journal - Cardiovascular Pharmacotherapy is 20556837, 20556845. An ISSN is an 8-digit code used to identify newspapers, journals, magazines and periodicals of all kinds and on all media–print and electronic.

European Heart Journal - Cardiovascular Pharmacotherapy - ISSN

European Heart Journal - Cardiovascular Pharmacotherapy - Subscription (non-OA) Journal

European Heart Journal - Cardiovascular Pharmacotherapy is a Subscription-based (non-OA) Journal. Publishers own the rights to the articles in their journals. Anyone who wants to read the articles should pay by individual or institution to access the articles. Anyone who wants to use the articles in any way must obtain permission from the publishers.

European Heart Journal - Cardiovascular Pharmacotherapy - Open Access

European Heart Journal - Cardiovascular Pharmacotherapy - Publisher

European Heart Journal - Cardiovascular Pharmacotherapy is published by Oxford University Press, which is located in the United Kingdom. The Publication History of European Heart Journal - Cardiovascular Pharmacotherapy covers 2015-ongoing.

European Heart Journal - Cardiovascular Pharmacotherapy - Publisher

European Heart Journal - Cardiovascular Pharmacotherapy - Categories

European Heart Journal - Cardiovascular Pharmacotherapy is a peer-reviewed scientific journal. The scope of European Heart Journal - Cardiovascular Pharmacotherapy covers Cardiology and Cardiovascular Medicine (Q1), Pharmacology (medical) (Q1).

European Heart Journal - Cardiovascular Pharmacotherapy - Categories

European Heart Journal - Cardiovascular Pharmacotherapy - Journal Metrics

It is impossible to get a true picture of impact using a single metric alone, so a basket of metrics is needed to support informed decisions. In addition to Abbreviation, Acceptance Rate, Review Speed, Research Hotspot and Template, several advanced Journal Metrics including Citescore, H-Index, Self-Citation Ratio, SJR (SCImago Journal Rank Indicator) and SNIP (Source Normalized Impact per Paper) can provide you comprehensive insights into the European Heart Journal - Cardiovascular Pharmacotherapy.

European Heart Journal - Cardiovascular Pharmacotherapy - Journal Metrics

Impact Factor 2018

Updated in 2019

6.723

People also search for: European Heart Journal, Circulation, Journal of the American College of Cardiology, Nature Reviews Cardiology, Circulation Research, more.

European Heart Journal - Cardiovascular Pharmacotherapy - Impact Factor

The Impact Factor 2018 of European Heart Journal - Cardiovascular Pharmacotherapy is 6.723, which is just updated in 2019. The Impact Factor Quartile of European Heart Journal - Cardiovascular Pharmacotherapy is Q1. The Impact Factor (IF) or Journal Impact Factor (JIF) of an academic journal is a scientometric index that reflects the yearly average number of citations that recent articles published in a given journal received. It is frequently used as a proxy for the relative importance of a journal within its field; journals with higher impact factors are often deemed to be more important than those with lower ones. The Impact Factor measures the average number of citations received in a particular year (2018) by papers published in the journal during the two preceding years (2016-2017). Note that 2018 impact factors are reported in 2019; they cannot be calculated until all of the 2018 publications have been processed by the indexing agency. Besides, 61% scientific research articles published by European Heart Journal - Cardiovascular Pharmacotherapy have received at least 1 citation in 2018. In addition to the 2-year Impact Factor, the 3-year Impact Factor and 5-year Impact Factor can provide further insights into the impact of European Heart Journal - Cardiovascular Pharmacotherapy.

 Impact Factor 2018-19


European Heart Journal - Cardiovascular Pharmacotherapy - Impact Factor Trend Prediction System

Impact Factor Trend Prediction System provides an open, transparent, and straightforward platform to help academic researchers Predict future journal impact and performance through the wisdom of crowds. Impact Factor Trend Prediction System displays the exact community-driven Data without secret algorithms, hidden factors, or systematic delay.

European Heart Journal - Cardiovascular Pharmacotherapy Impact Factor Trend Forecasting System
 Real-Time Impact Factor Prediction & 2017 2018 2019 IF Impact Factor Trend - Academic Accelerator
European Heart Journal - Cardiovascular Pharmacotherapy Impact Factor Trend. The chart clearly shows an uptrend of Impact Factor in 2018.
  • Impact Factor 2017 -
  • Impact Factor 2016 -
  • Impact Factor 2015 -

23


  • Article Volume 2017 -
  • Article Volume 2016 -
  • Article Volume 2015 -

Journal Ranking